Source: Annual Congress 2002 - Bench to bedside in lung injury
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
K. Katsoulis, T. N. Kontakiotis, L. Ganavias, D. Papakosta, D. Patakas (Thessaloniki, Greece). Measurement of serum total antioxidant status in patients with community acquired pneumonia: correlation with the severity of the disease. Eur Respir J 2002; 20: Suppl. 38, 1800

Member's Comments

No comment yet.

Related content which might interest you: Total antioxidant capacity and C-reactive protein levels in patients with community acquired pneumonia Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008 Plasma fibrinogen concentration is an independent marker of severity in patients with community acquired pneumonia Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008 Active oxygen forms and antioxidant blood status in patients with community acquired pneumonia and its combination with COPD Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021 Influence of older age on biomarker concentrations in patients with community acquired pneumonia Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 C-reactive protein (CRP) as a marker of disease severity in community acquired pneumonia patients with sepsis Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Elevated creatinine is a sensitive severity marker in community acquired pneumonia Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012 Associations of different serum 25(OH)D levels to parameters of respiratory health in COPD patients Source: Annual Congress 2011 - Respiratory epidemiology: genetics and modifiable risk factors Year: 2011 Prevalence of hyponatremia (HN) in children with community acquired pneumonia (CAP) and its relation to disease severity, outcomes Source: Virtual Congress 2021 – Acute paediatric respiratory infections Year: 2021 Relationship between health status and symptoms severity in sarcoidosis patients Source: Annual Congress 2007 - Granulomatous lung diseases including sarcoidosis Year: 2007 The relationship between level of C-reactive protein in blood serum and clinical manifestations of the disease in patients with pulmonary tuberculosis Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010 The prognostic importance of plasma D-dimer levels in patients with community acquired pneumonia Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 The diagnostic value of serum soluble CD 14 and IL-10 levels in newly diagnosed pulmonary tuberculosis patients and the relationship with disease extensity Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease? Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Does the serum C-reactive protein (CRP) predict adverse outcomes in patients admitted with community acquired pneumonia? Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 The relationship between the clinical symptoms, BALF cells and indices of respiratory function in patients with newly diagnosed sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 534s Year: 2004 Clinical profile and outcomes of patients with moderate and high risk community acquired pneumonia with mixed pathogens Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007 Correlation of depression levels and quality of life with severity of disease in COPD patients - A cross sectional study Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Relation between physical capacity, nutritional status and systemic inflammation in COPD patients Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates Year: 2008